Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome

Published:2023-02-01 Issue:3 Volume:207 Page:231-233
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

O’Kane Cecilia M.¹^ORCID,Matthay Michael A.²³^ORCID

Affiliation:

1. Wellcome Wolfson Institute for Experimental MedicineQueen’s University of BelfastBelfast, United Kingdom

2. Cardiovascular Research InstituteSan Francisco, California

3. Departments of Medicine and AnesthesiaUniversity of California San FranciscoSan Francisco, California

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202209-1838ED

Reference19 articles.

1. FiftyYearsofResearchinARDS.Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value

2. Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury

3. Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome?

4. Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS

5. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysis;Heliyon;2024-08

2. Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19;World Journal of Gastrointestinal Oncology;2024-05-15

3. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?;American Journal of Respiratory and Critical Care Medicine;2024-04-01

4. Anti-inflammatory therapies for acute respiratory distress syndrome;Expert Opinion on Investigational Drugs;2023-11-27

5. A Phase 2, randomized, double-blind, placebo-controlled multi-center trial sub-study for the clinical effects of paridiprubart treatment in hospitalized critically ill patients with COVID-19 ARDS;2023-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3